Was using NEU for comparison on a valuation basis only!
BOT and NEU are both ASX list biotech targeting the US market.
My point was to compare the MC of NEU currently on the amount of sales and income it's currently earning in the US and compare that with what BOT is expected to be earning from US sales and compare the valuations of the 2 Companies....
BOT - Anything but charting, page-5568
-
- There are more pages in this discussion • 5,950 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.8¢ |
Change
-0.018(5.07%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 32.5¢ | $1.187M | 3.543M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 673204 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 20520 | 3 |
View Market Depth
| Last trade - 13.54pm 04/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |